Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.
Key to Label Sections
C - Contraindications
W - Warnings
P - Precautions
AR - Adverse Reactions
Drug Name
Sections Modified
C
W
P
AR
Eribulin Mesylate Injection For Intravenous Administration